UBS O'Connor »

Cytokinetics shares owned by UBS O'Connor

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by UBS O'Connor from 13F filings

Historical chart of UBS O'Connor investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by UBS O'Connor

Quarter filed Position value Share count Share price at filing
2024-03-31 $210k 3.0k 70.11

More positions owned by UBS O'Connor

Spirit Air Note1 (Principal)
Peloton In Note2 (Principal)
Ryanair Ho Spons (RYAAY)
Revance Th Note1 (Principal)
Occidental Petroleum Corporation (OXY)
Okta Cla (OKTA)
NVIDIA Corporation (NVDA)
New Provid Class (NPAB)
Acorda The Note6 (Principal)
Bandwidth Note0 (Principal)
Screaming Class
Norfolk Southern (NSC)
Pentair Pl SHS (PNR)
Broadcom (AVGO)
Autoliv (ALV)

View all positions for UBS O'Connor

Top funds holding Cytokinetics

BlackRock
Vanguard Group
T. Rowe Price Investment Management
State Street Corporation
Darwin Global Management
Bank of America Corporation
Armistice Capital
Geode Capital Management
T. Rowe Price Associates
Pentwater Capital Management
Boxer Capital
Vestal Point Capital
Alliancebernstein
Partner Fund Management
Marshall Wace

View all funds holding Cytokinetics